jzg001

Jerald Gong, MD

Contact Dr. Gong

125 South 11th Street
Pavillion Building, Suite 301
Philadelphia, PA 19107

(215) 955-6304

Most Recent Peer-reviewed Publications

  1. Targeting BCL-W and BCL-XL as a therapeutic strategy for Hodgkin lymphoma
  2. Brentuximab vedotin in the treatment of CD301 PTCL
  3. Primary central nervous system plasmablastic lymphoma in an HIV-positive patient
  4. Mantle Cell Lymphoma with Hodgkin and Reed-Sternberg Cells: Review with Illustrative Case
  5. Extreme peripheral blood plasmacytosis mimicking plasma cell leukemia as a presenting feature of angioimmunoblastic T-cell lymphoma (AITL)
  6. Peripheral T-Cell lymphoma, not otherwise specified (PTCL-NOS)
  7. The Results of Hemoglobin Variant Analysis in Patients Revealing Microcytic Erythrocytosis on Complete Blood Count
  8. Myeloid Neoplasms Following Solid Organ Transplantation: Clinicopathologic Studies of 23 Cases
  9. Non-Hodgkin and Hodgkin lymphomas select for overexpression of BCLW
  10. Mitochondrial and glycolytic metabolic compartmentalization in diffuse large B-cell lymphoma
  11. Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment
  12. BCL-W has a fundamental role in B cell survival and lymphomagenesis
  13. Feasibility of Counting Smudge Cells as Lymphocytes in Differential Leukocyte Counts Performed on Blood Smears of Patients with Established or Suspected Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  14. EBV-associated peripheral t-cell lymphoma of gastrointestinal tract presented with widespread chronic inflammation: A case report
  15. Efficacy of DSP30-IL2/TPA for detection of cytogenetic abnormalities in chronic lymphocytic leukaemia/small lymphocytic lymphoma
  16. Assessment of the Reliability of the Sysmex XE-5000 Analyzer to Detect Platelet Clumps
  17. Bullous leukemia cutis in a patient with T-cell prolymphocytic leukemia
  18. Comparison of Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization for the Evaluation of MDM2 Amplification in Adipocytic Tumors
  19. Chronic neutrophilic leukaemia
  20. Validation of a next-generation-sequencing cancer panel for use in the clinical laboratory